Renaissance Technologies’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-153,716
Closed -$9.87M 3666
2026
Q1
$9.87M Buy
153,716
+96,400
+168% +$8.79M 0.02% 978
2025
Q4
$7.45M Buy
+57,316
New +$7.87M 0.01% 1069
2025
Q2
Sell
-70,216
Closed -$6.22M 3948
2025
Q1
$6.22M Sell
70,216
-134,900
-66% -$11.7M 0.01% 1292
2024
Q4
$15.8M Buy
205,116
+111,543
+119% +$7.79M 0.02% 770
2024
Q3
$3.97M Buy
93,573
+3,200
+4% +$108K 0.01% 1592
2024
Q2
$2.36M Buy
+90,373
New +$1.71M ﹤0.01% 1775
2023
Q2
Sell
-13,745
Closed -$166K 4305
2023
Q1
$166K Sell
13,745
-61,503
-82% -$820K ﹤0.01% 3342
2022
Q4
$655K Buy
75,248
+67,360
+854% +$1.48M ﹤0.01% 2782
2022
Q3
$228K Sell
7,888
-21,828
-73% -$999K ﹤0.01% 3334
2022
Q2
$1.24M Buy
29,716
+17,683
+147% +$1.2M ﹤0.01% 2566
2022
Q1
$1.22M Sell
12,033
-18,036
-60% -$2M ﹤0.01% 2599
2021
Q4
$4.43M Buy
+30,069
New +$6.72M 0.01% 1615

Other funds holding WGS

Renaissance Technologies's WGS Position: Q2 2026 in Review

Renaissance Technologies sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 153,716 shares — an estimated $9.87M sold.

Renaissance Technologies first reported a position in WGS in Q4 2021 and held it in 12 quarters. The position peaked at $15.8M in Q4 2024. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Renaissance Technologies reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 153,716 GeneDx Holdings shares in Q2 2026, an estimated $9.87M.
  • Renaissance Technologies first reported a position in GeneDx Holdings in Q4 2021 and held it in 12 quarters.
  • Renaissance Technologies's GeneDx Holdings position peaked at $15.8M in Q4 2024.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.